Hip Fracture Care During the COVID-19 Pandemic: Retrospective Cohort and Literature Review
Overview
Affiliations
Objectives: The goal of this study was to investigate whether the COVID-19 pandemic has affected hip fracture care at a Level I Trauma hospital. The secondary goal was to summarize the published hip fracture reports during the pandemic.
Design: A retrospective cohort study.
Setting: Level I Trauma Center.
Patients/participants: Eighty-six operatively treated hip fracture patients age ≥65 years, occurring from January 17 to July 2, 2020.
Intervention If Any: N/A.
Main Outcome Measurements: We defined 3 phases of healthcare system response: pre-COVID-19 (period A), acute phase (period B), and subacute phase (period C). The primary outcome was 30-day mortality. Clinical outcomes including time to surgery (TTS) and length of stay (LOS) were extracted from the electronic medical record.
Results: Twenty-seven patients from Period A, 27 patients from Period B, and 32 patients from Period C were included. The 30-day mortality was not statistically different. The mean TTS was 20.0 +/- 14.3 hours and was the longest in Period C (22.1 +/- 9.8 hours), but the difference was not statistically significant. The mean LOS was 113.0 +/- 66.2 hours and was longest in Period B (120.9 +/- 100.6 hours). However, the difference was not statistically significant.
Conclusions: The 30-day mortality, TTS, and LOS were not statistically different across multiple phases of pandemic at a level 1 trauma center. Our results suggest that we successfully adapted new protocol changes and continued to provide evidence-based care for hip fracture patients. Our results were comparable with that of other authors around the world.
Case T, Kricfalusi M, Ruckle D, Razzouk J, Dahan A, Elsissy J J Am Acad Orthop Surg Glob Res Rev. 2024; 8(7).
PMID: 38996219 PMC: 11239150. DOI: 10.5435/JAAOSGlobal-D-24-00178.
Arslan T, Sarac Z, Ersel M, Savas S Eur Geriatr Med. 2023; 14(6):1373-1381.
PMID: 37935942 DOI: 10.1007/s41999-023-00882-y.
Ding L, Wei J, Wang B J Am Med Dir Assoc. 2023; 24(6):846-854.
PMID: 37062371 PMC: 10027948. DOI: 10.1016/j.jamda.2023.03.011.